Presentation is loading. Please wait.

Presentation is loading. Please wait.

Swiss Life Sciences Trend Analysis 2016

Similar presentations


Presentation on theme: "Swiss Life Sciences Trend Analysis 2016"— Presentation transcript:

1 Swiss Life Sciences Trend Analysis 2016

2 About Us The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries. The Swiss Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with Swiss Biotech Association, Biotechnet, BaselArea and Life Sciences Zurich. Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy.

3 Overview of the Swiss Life-science Industry
2016 Statistics Total Biotech Companies 389 Medtech companies 206 Pharma companies 47 Investor companies 40 Public / Non-Profit Organizations / Medical Facilities 190 Other life science related companies 1135 Percentage of Publicly Owned Companies 2% Biotech Venture financing 2014 / 2015 USD 357.2m / USD 359m Life Sciences Venture Financing 2014 / 2015 USD / USD 782.4m Number of Technologies 192 Licensing Opportunities 55

4 Overview of the Swiss Biotechnology Industry
2016 Statistics Total Biotech companies 349 Biotech - Therapeutics 108 Biotech – R&D Services 173 Biotech - Other 68 Percentage of SMEs 81.1% Percentage of publicly owned companies 4.01% Biotech venture financing 2014/2015 USD 357.2m / USD 359m Licensing opportunities 40

5 Number of Employees

6 Company Ownership

7 Company Foundation Timeline

8 Key Activities of Biotechnology Companies

9 Biotech products - Breakdown by Indication

10 Products in the Pipeline

11 Biotechnology Financing in Switzerland – 5 year report

12 Major Biotech Financing Rounds (H2 2015 – H1* 2016)
Company Sector USD M ADC Therapeutics, Inc Biotech – Therapeutics & Diagnostics 80 Cardiorentis AG 60 ObsEva SA * Until May 2016

13 About Biotechgate Biotechgate contains over 38,000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data. To register for a trial or to learn more about the different subscription options, please visit

14 Terms of Use The “Swiss Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof. The use of the figures and graphs provided in this report is free of charge for any presentations as long as is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse 11 8004 Zurich Switzerland +41 (43)


Download ppt "Swiss Life Sciences Trend Analysis 2016"

Similar presentations


Ads by Google